title: Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force II: Acquired valvular heart disease.
authors.forename: M D
authors.initials: MD
authors.lastname: Cheitlin
authors.forename: R O
authors.initials: RO
authors.lastname: Bonow
authors.forename: W W
authors.initials: WW
authors.lastname: Parmley
authors.forename: W C
authors.initials: WC
authors.lastname: Roberts
authors.forename: H J
authors.initials: HJ
authors.lastname: Swan
authors.forename: J F
authors.initials: JF
authors.lastname: Williams
mesh_terms: D001022:Aortic Valve Insufficiency / Q000175:diagnosis / Q000503:physiopathology; D001024:Aortic Valve Stenosis / Q000175:diagnosis / Q000503:physiopathology; D006349:Heart Valve Diseases / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology; D006350:Heart Valve Prosthesis; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000175:diagnosis / Q000503:physiopathology; D008946:Mitral Valve Stenosis / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D013177:Sports; D013178:Sports Medicine; D014262:Tricuspid Valve Insufficiency / Q000175:diagnosis / Q000503:physiopathology